zoledronic acid has been researched along with Fibrosis in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L; Cheng, L; Chi, W; Deng, H; Feng, Y; Ge, M; Hu, X; Huang, Y; Huo, Y; Kuang, W; Lan, Z; Li, L; Liu, X; Liu, Y; Luo, M; Ma, Z; Siegenthaler, JA; Sun, K; Xi, Q; Xu, L; Yang, J; Zhang, B; Zhang, Y; Zhao, X | 1 |
| Baas, J; Jakobsen, T; Kold, S; Rahbek, O; Shiguetomi-Medina, J; Soballe, K | 1 |
| Alves, A; Arnoldi, J; Procter, P | 1 |
| Chosa, N; Ibi, M; Ishisaki, A; Kamo, M; Komatsu, Y; Kyakumoto, S; Shibata, T; Sugiyama, Y | 1 |
| Guarniero, R; Matos, MA; Tannuri, U | 1 |
| Blanchard, F; Charrier, C; Coipeau, P; Couillaud, S; Gouin, F; Heymann, D; Heymann, MF; Ory, B; Redini, F; Thiery, JP | 1 |
6 other study(ies) available for zoledronic acid and Fibrosis
| Article | Year |
|---|---|
Zoledronate dysregulates fatty acid metabolism in renal tubular epithelial cells to induce nephrotoxicity.
Topics: Animals; Benzamides; Cell Line; Coenzyme A Ligases; Dioxoles; Epithelial Cells; Fatty Acids; Fenofibrate; Fibrosis; Humans; Kidney Diseases; Kidney Tubules; Lipid Metabolism; Male; Mice, Inbred C57BL; Mice, Mutant Strains; Oxidation-Reduction; Transforming Growth Factor beta; Zoledronic Acid | 2018 |
Topical zoledronic acid decreases micromotion induced bone resorption in a sheep arthroplasty model.
Topics: Animals; Bone Density Conservation Agents; Bone Resorption; Diphosphonates; Drug Evaluation, Preclinical; Fibrosis; Imidazoles; Prosthesis Failure; Sheep; Zoledronic Acid | 2017 |
Early tissue responses to zoledronate, locally delivered by bone screw, into a compromised cancellous bone site: a pilot study.
Topics: Animals; Bone Resorption; Bone Screws; Coated Materials, Biocompatible; Diphosphonates; Drug Evaluation, Preclinical; Exudates and Transudates; Femur; Fibrin; Fibrinogen; Fibrosis; Imidazoles; Implants, Experimental; Macrophages; Male; Mesoderm; Osseointegration; Osteoclasts; Pilot Projects; Rabbits; Titanium; Zoledronic Acid | 2014 |
Zoledronic acid suppresses transforming growth factor-β-induced fibrogenesis by human gingival fibroblasts.
Topics: Animals; Cell Differentiation; Cell Movement; Cell Survival; Diphosphonates; Fibroblasts; Fibrosis; Gingiva; Humans; Imidazoles; Mice; Myofibroblasts; NIH 3T3 Cells; Phosphorylation; Protein Serine-Threonine Kinases; Receptor, Transforming Growth Factor-beta Type I; Receptors, Transforming Growth Factor beta; Smad Proteins; Transforming Growth Factor beta; Zoledronic Acid | 2016 |
The effect of zoledronate during bone healing.
Topics: Animals; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Bony Callus; Diphosphonates; Fibrosis; Fracture Healing; Imidazoles; Male; Osteoclasts; Osteotomy; Rabbits; Zoledronic Acid | 2010 |
Enhanced tumor regression and tissue repair when zoledronic acid is combined with ifosfamide in rat osteosarcoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bone Remodeling; Caspases; Cell Line, Tumor; Cell Proliferation; Diphosphonates; Fibrosis; Ifosfamide; Imidazoles; Male; Necrosis; Neoplasm Metastasis; Neoplasm Recurrence, Local; Osteoblasts; Osteogenesis; Osteosarcoma; Rats; Rats, Sprague-Dawley; S Phase; Survival Rate; Tibia; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Zoledronic Acid | 2005 |